Cargando…
Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples
A variety of serological tests have been developed to detect the presence of antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We evaluated the performance of 18 commercially available SARS-CoV-2 antibody assays. Early (6–8 days after the start of symptoms) and lat...
Autores principales: | Hanssen, Daniëlle A. T., Slaats, Michiel, Mulder, Marlies, Savelkoul, Paul H. M., van Loo, Inge H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968571/ https://www.ncbi.nlm.nih.gov/pubmed/33733395 http://dx.doi.org/10.1007/s10096-021-04220-7 |
Ejemplares similares
-
Antibodies against SARS-CoV-2 after natural infection in healthcare workers and clinical characteristics as putative antibody production prediction
por: Hanssen, D.A.T., et al.
Publicado: (2022) -
Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: Hashem, Anwar M., et al.
Publicado: (2020) -
Systematic reference sample generation for multiplexed serological assays
por: Planatscher, Hannes, et al.
Publicado: (2013) -
Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay
por: Vande Casteele, Niels, et al.
Publicado: (2023) -
Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance
por: Nicholson, Suellen, et al.
Publicado: (2021)